Celator Pharmaceuticals, Inc. CPXX
Just under a couple of weeks ago, we chose to alert CPXX in our morning report from May 19th. The stock had been gaining significant ground in sessions prior to that, to the point we felt it warranted our attention.
It was a good thing we drew attention to it when we did, because what followed was a solid run-up from our observed low of 15.73 into the $18-range. This morning, our witnessed gains received yet another big boost, as a takeover has been announced that will see CPXX acquired by Jazz Pharmaceuticals for $1.5B, or, 30.25 a share.
As of this morning’s premarket high on CPXX, our observed PPS increase on the stock in a matter of just seven trading sessions has been extended to a very solid 95%
- Jazz Pharmaceuticals And Celator Pharmaceuticals Announce Agreement For Jazz Pharmaceuticals To Acquire Celator For $30.25 Per Share (Tue 3:30AM EDT)
Lending Club Corp. LC
Speaking of extended gains from plays that we’ve been discussing recently, we also had LC put up a noteworthy performance on Friday that culminated in new highs for us since we began tracking the stock.
Just to refresh our readers’ memories, we called LC as a bottom-bounce candidate last Monday, at which time we observed a low of 4.19. Friday’s run carried it to a high of 5.10, marking an intraweek move of 22%
We’re going to want to continue to monitor its progress as the chart is still looking quite ripe for a continued uptrend. As you can see on the provided chart snapshot, we’ve got a steadily-strengthening RSI combined with a recent bullish MACD cross in addition to a significant gap on the chart that runs from the 5.50’s to the 6.70’s.
Cliffs Natural Resources, Inc. CLF
We’re also going to place a tag on CLF this morning. We like the recent activity and the look of the current chart. Like the aforementioned play, we’re faced with a number of bullish indicators that are urging us to keep CLF on our radars as we kick off a new trading week.
CATS, NHMD, SQI, GEVO, NERV, FRO